A clinician-guided, whole-person metabolic health program offered as an employer benefit and paid directly by the employee.
Strata’s GLP-1 program goes beyond medication alone. Members receive GLP-1 therapy as part of a structured, 12-month plan with clinical oversight, lab monitoring, and ongoing support to help build healthy, sustainable outcomes.
Strata’s GLP-1 employer benefit is a voluntary, employee-paid metabolic health program that provides GLP-1 medication within a clinically supervised, whole-person care model.
This is not a medication-only or self-directed GLP-1 option. Strata’s program is designed to prioritize safety, accountability, and long-term health—not quick fixes or hype.
GLP-1 therapy is positioned as one tool in a broader wellbeing toolkit, paired with services that help members create lasting change.
The program includes clinical review, safety monitoring, adherence reminders, and clear escalation protocols. Medication shipments may be paused if adherence or safety requirements are not met.
This is a defined program with eligibility criteria, check-in cadence, and monitoring—not an open-ended prescription.
Your Strata GLP-1 plan includes:
Choose the medication that fits your care plan. Your membership covers the full program — clinical oversight, labs, and ongoing support.
Semaglutide
$139/mo
Compounded semaglutide injection
Tirzepatide
$179/mo
Compounded tirzepatide injection
*Billed quarterly. A 90-day supply is shipped and billed for all three months upon scripting of your medication.
This program is offered as an optional employer benefit, allowing employees to access a clinically monitored GLP-1 program with employer-supported infrastructure—while the employee covers the cost of participation.
This model provides:
Self-directed GLP-1 options may seem convenient, but they often lack structured oversight.
The FDA has cautioned against unapproved GLP-1 versions and highlighted risks associated with compounded products, including concerns related to quality, safety, and shipping/storage temperature.
Strata’s program stays clinician-led, safety-focused, and accountability-driven, so members are supported throughout the journey—not left to manage it alone.
This program may be appropriate for employees who:
Enrollment is subject to clinical eligibility and program requirements.
GLP-1 medications can cause side effects, most commonly digestive symptoms that often improve over time. The Strata program includes education on what to expect, when to check in, and how concerns are addressed through clinical escalation protocols.
If you’re considering GLP-1 therapy, Strata offers a program designed around safety, accountability, and long-term wellbeing.
Use your company-specific application link. Contact your HR team or Strata Med for that link.
Applying independently? Explore the Individual GLP-1 Program.